VR
Venkata Ramana Motupalli
About Venkata Ramana Motupalli
Data last updated:
Venkata Ramana Motupalli is a Director at Aurigene Oncology Limited (since 2023), Director at Svaas Wellness Limited (since 2020) and Director at Dr. Reddy's And Nestle Health Science Limited (since 2024). The companies operate in Life Sciences, Internet and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹200 Cr; the largest is Aurigene Oncology Limited at ₹172 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aurigene Oncology Limited U24239KA2001PLC029391 | Director | 19 Oct 2023 | 2001 | ₹172 Cr (FY 2025) | Active |
 Svaas Wellness Limited U85100TG2009PLC064271 | Director | 26 Dec 2020 | 2009 | ₹28.53 Cr (FY 2025) | Active |
 Dr. Reddy's And Nestle Health Science Limited U46497TS2024PLC183328 | Director | 14 Mar 2024 | 2024 | Active |
Board colleagues of Venkata Ramana Motupalli
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venkata Ramana Motupalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venkata Ramana Motupalli
Venkata Ramana Motupalli currently holds 3 directorships: Aurigene Oncology Limited (Director, since 19 Oct 2023, revenue ₹172 Cr (FY 2025)); Svaas Wellness Limited (Director, since 26 Dec 2020, revenue ₹28.53 Cr (FY 2025)); Dr. Reddy's And Nestle Health Science Limited (Director, since 14 Mar 2024).
Venkata Ramana Motupalli was first appointed on 26 Dec 2020 as Director at Svaas Wellness Limited. The most recent appointment on record is 14 Mar 2024 at Dr. Reddy's And Nestle Health Science Limited.
The 2 current companies of Venkata Ramana Motupalli that report revenue have a combined latest revenue of ₹200 Cr: Aurigene Oncology Limited ₹172 Cr (FY 2025); Svaas Wellness Limited ₹28.53 Cr (FY 2025).
The current boards of Venkata Ramana Motupalli's companies include Brijesh Kumar Karnani (Aurigene Oncology Limited), Bruce Leonard Andrews Carter (Aurigene Oncology Limited), Buggana Hariharnath (Aurigene Oncology Limited), Kumar Srinivasan (Aurigene Oncology Limited), Muralidhara Ramachandra (Aurigene Oncology Limited), Muralidhara Ramachandra (Aurigene Oncology Limited), among others.